These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8652214)

  • 1. Inhaled hypertonic saline increases sputum expectoration in cystic fibrosis.
    Riedler J; Reade T; Button B; Robertson CF
    J Paediatr Child Health; 1996 Feb; 32(1):48-50. PubMed ID: 8652214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
    Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hypertonic saline nebulisation combined with oscillatory positive expiratory pressure on sputum expectoration and related symptoms in cystic fibrosis: a randomised crossover trial.
    San Miguel-Pagola M; Reychler G; Cebrià I Iranzo MA; Gómez-Romero M; Díaz-Gutiérrez F; Herrero-Cortina B
    Physiotherapy; 2020 Jun; 107():243-251. PubMed ID: 32026826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Hypertonic Saline Solutions on Sputum Expectoration and Their Safety Profile in Patients with Bronchiectasis: A Randomized Crossover Trial.
    Herrero-Cortina B; Alcaraz V; Vilaró J; Torres A; Polverino E
    J Aerosol Med Pulm Drug Deliv; 2018 Oct; 31(5):281-289. PubMed ID: 29878856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.
    Brivio A; Conese M; Gambazza S; Biffi A; Tirelli AS; Russo M; Foà M; Colombo C
    J Aerosol Med Pulm Drug Deliv; 2016 Dec; 29(6):482-489. PubMed ID: 27149365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I.
    King M; Dasgupta B; Tomkiewicz RP; Brown NE
    Am J Respir Crit Care Med; 1997 Jul; 156(1):173-7. PubMed ID: 9230743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial to evaluate the lung clearance index as an outcome measure for early phase studies in patients with cystic fibrosis.
    Amin R; Stanojevic S; Kane M; Webster H; Ratjen F
    Respir Med; 2016 Mar; 112():59-64. PubMed ID: 26856191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.
    Subbarao P; Balkovec S; Solomon M; Ratjen F
    Pediatr Pulmonol; 2007 May; 42(5):471-6. PubMed ID: 17436328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study.
    Stahl M; Wielpütz MO; Ricklefs I; Dopfer C; Barth S; Schlegtendal A; Graeber SY; Sommerburg O; Diekmann G; Hüsing J; Koerner-Rettberg C; Nährlich L; Dittrich AM; Kopp MV; Mall MA
    Am J Respir Crit Care Med; 2019 May; 199(10):1238-1248. PubMed ID: 30409023
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis.
    Kellett F; Redfern J; Niven RM
    Respir Med; 2005 Jan; 99(1):27-31. PubMed ID: 15672845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of hypertonic saline nebulization in airway clearance in children with non-cystic fibrosis bronchiectasis: A randomized control trial.
    Anuradha KWDA; Gunathilaka PKG; Wickramasinghe VP
    Pediatr Pulmonol; 2021 Feb; 56(2):509-515. PubMed ID: 33295693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.
    Corcoran TE; Godovchik JE; Donn KH; Busick DR; Goralski J; Locke LW; Markovetz MR; Myerburg MM; Muthukrishnan A; Weber L; Lacy RT; Pilewski JM
    Pediatr Pulmonol; 2017 Sep; 52(9):1142-1149. PubMed ID: 28737262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute inhalation of hypertonic saline does not improve mucociliary clearance in all children with cystic fibrosis.
    Laube BL; Sharpless G; Carson KA; Kelly A; Mogayzel PJ
    BMC Pulm Med; 2011 Sep; 11():45. PubMed ID: 21896198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial.
    Nenna R; Midulla F; Lambiase C; De Castro G; Zicari AM; Indinnimeo L; Cimino G; Troiani P; Quattrucci S; Tancredi G
    Ital J Pediatr; 2017 Jul; 43(1):60. PubMed ID: 28709466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of obtaining sputum and cough swab samples following inhaled hypertonic saline in children with cystic fibrosis.
    Ho SA; Ball R; Morrison LJ; Brownlee KG; Conway SP
    Pediatr Pulmonol; 2004 Jul; 38(1):82-7. PubMed ID: 15170878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function.
    Amin R; Subbarao P; Jabar A; Balkovec S; Jensen R; Kerrigan S; Gustafsson P; Ratjen F
    Thorax; 2010 May; 65(5):379-83. PubMed ID: 20435858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertonic Saline as a Useful Tool for Sputum Induction and Pathogen Detection in Cystic Fibrosis.
    Ferreira ACM; Marson FAL; Cohen MA; Bertuzzo CS; Levy CE; Ribeiro AF; Ribeiro JD
    Lung; 2017 Aug; 195(4):431-439. PubMed ID: 28455785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M; Dentice R
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008816. PubMed ID: 22336853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2000; (2):CD001506. PubMed ID: 10796798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis.
    Kellett F; Robert NM
    Respir Med; 2011 Dec; 105(12):1831-5. PubMed ID: 22018993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.